A multicenter, randomized study to evaluate the efficacy and safety of mesalamine suppositories 1 g at bedtime and 500 mg Twice daily in patients with active mild-to-moderate ulcerative proctitis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples